IH
Ivan Hyep (Chief Financial Officer) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $783K of BCAX (27,170 sh across 2 lots, as filed), executed Jul 8. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
8
0 buys · 8 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.1M
shares × price, as filed
Last traded
Aug 10
Filed Aug 12
Median ADV $19.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
8 filings
Sector per market data · by filing · past 12 months
Most traded names
BCAXRecent filings
BCAXSALE
Bicara Therapeutics Inc.
View filing →
$117K6,415 sh × $18.23
Exec Oct 9 2025
Filed Oct 10 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $553K
30,385 sh across 3 lots
Exec Oct 6 2025
Filed Oct 8 2025 · 5:30 PM ET